"We will continue to supply these active ingredients to meet its obligations to our customers", it added.

The company will respond to this warning letter with a detailed plan within the stipulated time, Divis Laboratories said.

Earlier on March 22, Divis Laboratories had said in a regulatory filing that the regulator had issued import alert for products made at Visakhapatnam unit citing violation of manufacturing norms and refusal of inspection.

Subscribe to our Newsletters

Earlier people used to visit a pharmacy or a medical store only when they used to be sick but today there is an evolving trend. Now people have suddenly realized that there is a huge potential in being healthy.